3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow MK-4721: new trials by email Literature Review of MK-4721 trials Research Report on MK-4721
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 AGS-1C4D4, gemcitabine - Pancreatic Cancer, Carcinoma, Pancreatic Ductal | Phase 2 | Completed | Agensys, Inc. | 2 | 2012-08-07 | 2017-05-16 |
| A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer AGS-1C4D4, Gemcitabine - Carcinoma, Pancreatic Ductal, Pancreatic Cancer | Phase 2 | Completed | Astellas Pharma Inc | 205 | 2009-04-01 | 2015-09-14 |
| AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer AGS-1C4D4 - Prostate Cancer | Phase 1 | Completed | Astellas Pharma Inc | 13 | 2007-09-01 | 2014-05-02 |
Carcinoma, Pancreatic Ductal (2) · Pancreatic Diseases (2) · Pancreatic Neoplasms (2) · Prostatic Neoplasms (1)
Astellas Pharma Inc (2) · Agensys, Inc. (1)
United States (3) · Canada (2) · France (1) · Russia (1) · Spain (1)
2009 (1)